Quick Answer
Roivant Sciences Ltd. reported Total Assets of $5.44 billion for the year ending 2025.
- Roivant Sciences Ltd. showed a decrease of -24.7% in Total Assets from 2024 to 2025.
- This data is from Roivant Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on May 29, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $2.45 billion | Q3 2021: $3.10 billion | Q4 2021: $2.80 billion | Q2 2022: $2.60 billion | Q3 2022: $2.22 billion | Q4 2022: $2.20 billion | Q2 2023: $2.14 billion | Q3 2023: $2.07 billion | Q4 2023: $7.31 billion | Q2 2024: $6.50 billion | Q3 2024: $6.21 billion | Q4 2024: $5.79 billion | Q1 2025: $5.44 billion | Q2 2025: $5.03 billion | Q3 2025: $5.06 billion | Q4 2025: $5.23 billion.
- Over the full 5 years of available data (2021 to 2025), Roivant Sciences Ltd.'s Total Assets has grown by 109.9%.
- Historical annual values: Fiscal year 2025: $5.44 billion | Fiscal year 2024: $7.22 billion | Fiscal year 2023: $2.39 billion | Fiscal year 2022: $2.59 billion | Fiscal year 2021: $2.59 billion.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: